| R11714 |
2-Butenoic acid, 3-[(trimethylsilyl)oxy]-, ethyl ester |
|
| R11715 |
Ufiprazole |
|
| R11716 |
Esomeprazole magnesium |
|
| R11717 |
6-Bromo-3-nitro-4-quinolinol |
|
| R11718 |
2-MERCAPTOPYRIMIDINE-4,6-DIOL |
|
| R11719 |
2-Thiobarbituric acid sodium |
|
| R11720 |
4,6-Dichloro-5-nitro-2-propylthiopyridine |
|
| R11721 |
4,6-dichloro-2-(n-propylsulfanyl)pyrimidine |
|
| R11722 |
4-Mercaptomethyl-3,6-dithia-1,8-octanedithiol |
|
| R11723 |
Iberdomide (CC-220) |
Iberdomide (CC-220) is a cereblon (CRBN) modulator with an IC50&n
|
| R11724 |
tri-ortho-cresyl phosphate |
|
| R11725 |
(S)-tert-butyl 2-cyanopyrrolidine-1-carboxylate |
|
| R11726 |
RO0921 |
RO9021 is an orally bioavailable, novel ATP-competitive inhibitor of SYK, w
|
| R11727 |
OTS514 |
OTS514 is a highly potent TOPK inhibitor, which inhibits TOPK kinase a
|
| R11728 |
Ochratoxin A |
|
| R11729 |
6-amino-1,3-dimethyl-1H-quinolin-2-one |
CAS NO.：1425927-75-8Product Name：6-amino-1,3-dimethyl-1H-quinolin-2-oneSynonyms：
|
| R11730 |
3-amino-1-phenethyl-1H-pyrazole-4-carbonitrile |
CAS NO.：159979-72-3Product Name：3-amino-1-phenethyl-1H-pyrazole-4-carbonitrileSy
|
| R11731 |
ethyl 3,6-dichloropyridazine-4-carboxylate |
|
| R11732 |
2-amino-5,6-dimethylpyridine |
|
| R11733 |
9-bromo-8-methoxy-6-methylthieno[2,3-c]quinolin-4(5H)-one |
|
| R11734 |
6-chloro-1H-pyrazolo[3,4-b]pyridine |
|
| R11735 |
2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)propanoate |
|
| R11736 |
2'-Fluoro-2'-deoxyadenosine |
|
| R11737 |
(2S)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]-8-nonenoic acid |
|
| R11738 |
NVP-CGM097 (CGM097) |
NVP-CGM097 is a potent and selective MDM2 inhibitor with IC50&nbs
|
